Curcumin suppresses intestinal polyps in APC Min mice fed a high fat diet

Christina Pettan-Brewer, John Morton, Ruby Mangalindan, Warren Ladiges, Christina Pettan-Brewer, John Morton, Ruby Mangalindan, Warren Ladiges

Abstract

Colorectal cancer (CRC) is a leading cause of cancer deaths in the United States. Various risk factors have been associated with CRC including increasing age and diet. Epidemiological and experimental studies have implicated a diet high in fat as an important risk factor for colon cancer. High fat diets can promote obesity resulting in insulin resistance and inflammation and the development of oxidative stress, increased cell proliferation, and suppression of apoptosis. Because of the high consumption of dietary fats, especially saturated fats, by Western countries, it is of interest to see if non-nutrient food factors might be effective in preventing or delaying CRC in the presence of high saturated fat intake. Curcumin (Curcuma longa), the main yellow pigment in turmeric, was selected to test because of its reported anti-tumor activity. APC Min mice, which develop intestinal polyps and have many molecular features of CRC, were fed a diet containing 35% pork fat, 33% sucrose, and a protein and vitamin mineral mixture (HFD) with or without 0.5% curcumin. These cohorts were compared to APC Min mice receiving standard rodent chow (RC) with 8% fat. APC Min mice fed the HFD for 3 months had a 23% increase in total number of polyps compared to APC Min mice on RC. Curcumin was able to significantly reverse the accelerated polyp development associated with the HFD suggesting it may be effective clinically in helping prevent colon cancer even when ingesting high amounts of fatty foods. The anti-tumor effect of curcumin was shown to be associated with enhanced apoptosis and increased efficiency of DNA repair. Since curcumin prevented the gain in body weight seen in APC Min mice ingesting the HFD, modulation of energy metabolism may also be a factor.

Keywords: DNA damage; apoptosis; colon cancer; curcumin; high fat diet; oxidative stress.

Figures

Fig. 1
Fig. 1
The number of small-sized polyps (up to 3 mm in diameter) in the small intestine of APC Min mice fed a high fat (HF) diet is increased compared to the number of polyps in mice fed chow (*p≤0.05). When curcumin (C) is added to the HF diet, small-sized polyp numbers are attenuated compared to polyp numbers in mice ingesting HF diet without curcumin (*p≤0.05). N=15–18 mice for each of the three cohorts.
Fig. 2
Fig. 2
Apoptosis, as assessed immunohistochemically by apoptotic index, is increased in intestinal polyps from APC Min mice ingesting high fat (HF) diet with curcumin (C), but not in polyps from APC Min mice ingesting HF diet without curcumin or regular rodent chow diet (*p≤0.05). N=15–18 mice for each of the cohorts.
Fig. 3
Fig. 3
Oxidation-induced DNA damage, as assessed immunohistochemically by 8-oxoG index, in intestinal polyps from APC Min mice is not affected by ingestion of a high fat (HF) diet with or without curcumin. However, ingestion of the HF diet appears to attenuate oxidation-induced DNA damage observed in non-polyp tissue from APC Min mice ingesting regular rodent chow (*p≤0.05). N=15–18 mice for each of the cohorts.
Fig. 4
Fig. 4
DNA repair activity, as assessed immunohistochemically by XRCC1 expression index, is increased in intestinal polyps from APC Min mice fed high fat (HF) diet with curcumin (C) compared to APC Min mice ingesting HF diet without curcumin or regular rodent chow (*p≤0.05). Interestingly, the XRCC1 expression index is decreased in intestinal non-polyp tissue from APC Min mice ingesting HF diet with or without curcumin compared to APC Min mice ingesting regular rodent chow (*p≤0.05). N=15–18 mice for each of the cohorts.
Fig. 5
Fig. 5
Body weights of APC Min mice fed a diet high in fat and calories with curcumin added (HFHC+C) or without curcumin (HFHC) or fed regular rodent chow (RC). Starting at week 4, body weight is significantly lower in APC Min mice ingesting the high fat diet containing curcumin (N=32) compared to APC Min mice ingesting the high fat diet without curcumin (N=32; p<0.01) and is comparable to body weight of APC Min mice ingesting regular rodent chow.

References

    1. Boutron-Ruault MC, Senesse P, Faivre J, Chatelain N, Belghiti C, Meance S. Food as a risk factor for colorectal cancer: a case-control study in Burgundy. J Cancer Prev. 1999;8:229–35.
    1. Peto J. Progress: cancer epidemiology in the last century and the next decade. Nature. 2001;411:390.
    1. Wasan HS, Novelli M, Bee J, Bodmer WF. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. Proc Nat Acad Sci USA. 1997;94:3308–13.
    1. Newmark HL, Yang K, Lipkin M, Kopelovich L, Liu Y, Fan K, et al. A western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis. 2001;22:1871–5.
    1. Martínez ME. Primary prevention of colorectal cancer: lifestyle, nutrition, exercise. Recent results in cancer research. Fortschritte Der Krebsforschung. Progrés Dans Les Recherches Sur Le Cancer. 2005;166:177–211.
    1. Ugajin H. The role of bile acids with physiological concentration in colon carcinogenesis. Nippon Shokakibyo Gakkai Zasshi. 1989;86:1617–26.
    1. Rabolli D, Martin RJ. Effects of diet composition on serum levels of insulin, thyroxine, triiodothyronine, growth hormone, and corticosterone in rats. J Nutr. 1977;107:1068–74.
    1. Rosen ED, Spiegelman BM. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Bio Chem. 2001;276:37731–4.
    1. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med. 1990;323:1664–72.
    1. Byers T. Diet, colorectal adenomas, and colorectal cancer. N Engl J Med. 2000;342:1206.
    1. Han Y, Haraguchi T, Iwanaga S, Tomotake H, Okazaki Y, Mineo S, et al. Consumption of some polyphenols reduces fecal deoxycholic acid and lithocholic acid, the secondary bile acids of risk factors of colon cancer. J Agric Food Chem. 2009;57:8587–90.
    1. Pearson JR, Gill CI, Rowland IR. Diet, fecal water, and colon-cancer – development of a biomarker. Nutr Rev. 2009;67:509–26.
    1. Vogel U, Danesvar B, Autrup H, Risom L, Weimann A, Poulsen HE, et al. Effect of increased intake of dietary animal fat and fat energy on oxidative damage, mutation frequency, DNA adduct level and DNA repair in rat colon and liver. Free Radic Res. 2003;37:947–56.
    1. World Cancer Research Fund. Food, nutrition and the prevention of cancer, a global perspective. 2008. Available from: [cited 27 November 2008]
    1. Moller P, Loft S. Interventions with antioxidants and nutrients in relation to oxidative DNA damage and repair. Mutat Res. 2004;551:1–2.
    1. Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, et al. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res. 1999;59:597–601.
    1. Collett GP, Robson CN, Mathers JC, Campbell FC. Curcumin modifies Apc (min) apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour formation in Apc(min) mice. Carcinogenesis. 2001;22:821–5.
    1. Perkins S, Verschoyle RD, Hill K, Parveen I, Threadgill MD, Sharma RA, et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiology, Biomarkers & Prevention: a publication of the Am Assoc Can Res cosponsored by Am Soc Prev Oncology. 2002;11:535–40.
    1. Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res: J Am Assoc Cancer Res. 2004;10:6847–54.
    1. Nakamura Y, Ohto Y, Murakami A, Osawa T, Ohigashi H. Inhibitory effects of curcumin and tetrahydrocurcuminoids on the tumor promoter-induced reactive oxygen species generation in leukocytes in vitro and in vivo . Jpn J Cancer Res. 1998;89:361.
    1. Johnson JJ, Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Lett. 2007;255:170–81.
    1. Sharma OP. Antioxidant activity of curcumin and related compounds. Biochem Pharmacol. 1976;25:1811–2.
    1. Osawa T, Sugiyama Y, Inayoshi M, Kawakishi S. Antioxidative activity of tetrahydrocurcuminoids. Biosci Biotech Biochem. 1995;59:1609.
    1. Sugiyama Y, Kawakishi S, Osawa T. Involvement of the β-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem Pharm. 1996;52:519.
    1. Joe B, Vijaykumar M, Lokesh BR. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr. 2004;44:97–112.
    1. López-Lázaro M. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol Nutr Food Res. 2008;52:103–27.
    1. Li N, Chen X, Liao J, Yang G, Wang S, Josephson Y, et al. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis. 2002;23:1307–13.
    1. Polasa K, Naidu AN, Ravindranath I, Krishnaswamy K. Inhibition of B(a)P induced strand breaks in presence of curcumin. Mutat Res. 2004;557:203–13.
    1. Ladiges WC, Knoblaugh SE, Morton JF, Korth MJ, Sopher BL, Baskin CR, et al. Pancreatic beta-cell failure and diabetes in mice with a deletion mutation of the endoplasmic reticulum molecular chaperone gene P581PK. Diabetes. 2005;54:1074–81.
    1. Tanito M, Nishiyama A, Tanaka T, Masutani H, Nakamura H, Yodoi J, et al. Change of redox status and modulation by thiol replenishment in retinal photoxidative damage. Invest Ophthamol Vis Sci. 2002;43:2392–400.
    1. Rao CV, Hirose Y, Indranie C, Reddy BS. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res. 2001;61:1927–33.
    1. Mahmoud NN, Carothers AM, Grumberger D, Bilinski RT, Churchill MR, Martucci C, et al. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis. 2000;21:921–7.
    1. Jackson LN, Evers BM. Regulation of proliferation, apoptosis and cell cycle in gastrointestinal disorders. Curr Opin Pharmacol. 2009;9:708–14.
    1. Scott DW, Loo G. Curcumin induced GADD153 upregulation: modulation by glutathione. J Cell Biochem. 2007;101:307–20.
    1. Beevers CS, Chen L, Liu L, Luo Y, Webster NJ, Huang S. Curcumin disrupts the mammalian target of rapamycin-raptor complex. Cancer Res. 2009;69:1000–8.
    1. van Loon B, Markkanen E, Hübscher U. Oxygen as a friend and enemy: how to combat the mutational potential of 8-oxoguanine. DNA Repair (Amst) 2010;9:604–16.
    1. Ladiges WC. Mouse models of XRCC1 DNA repair polymorphisms and cancer. Oncogene. 2006;25:1612–9.
    1. Baltgalvis KA, Berger FG, Pena MM, Davis GM, Carson JA. The interaction of a high-fat diet and regular moderate intensity exercise on intestinal polyp development in Apc Min/+ mice. Cancer Prev Res. 2009;2:641–9.
    1. Mai V, Colbert LH, Berrigan D, Perkins SN, Pfeiffer R, Lavigne JA, et al. Caloric restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms. Cancer Res. 2003;63:1752–5.
    1. Gunter MJ, Leitzmann MF. Obesity and colorectal cancer; epidemiology, mechanisms and candidate genes. J Nutr Biochem. 2006;17:145–56.
    1. Ejaz A, Wu D, Kwan P, Meydani M. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr. 2009;139:919–25.

Source: PubMed

3
Abonnieren